| ||||||||||||||
|
|
|||||||||||||
Department of Anesthesiology & Reanimatology, Gunma University School of Medicine, Gunma, Japan
Address correspondence and reprint requests to Shigeru Saito, MD, PhD, Department of Anesthesiology & Reanimatology, Gunma University School of Medicine, 3-39-22, Showa-machi, Maebashi, 371-8511, Gunma, Japan. Address e-mail to shigerus{at}showa.gunma-u.ac.jp
| Abstract |
|---|
|
|
|---|
IMPLICATIONS: Local anesthetics induce growth cone collapse and neurite degeneration in the growing neurons. Mepivacaine was safer than lidocaine, bupivacaine, and ropivacaine for the primary cultured chick neurons.
| Introduction |
|---|
|
|
|---|
Substantial evidence suggests that, in some cases, impairment results from a direct neurotoxic effect of the local anesthetic (2,5,6). The neural trauma and transient ischemia were suggested to be contributing factors in the neurological complications that accompanied regional anesthesia in clinical settings (7). The precise morphological changes induced by direct application of local anesthetics to neurons are not yet fully understood. Recently, Saito et al. (8) have showed that tetracaine produced irreversible changes in growing cultured neurons, and the growth cones were the most quickly affected. This report implies that the clinically used local anesthetic, tetracaine, might have significant effects on neuronal extension in developing or regenerating nervous tissue. Because local anesthetics are sometimes applied to sites where peripheral nerves may be growing or regenerating after injury (e.g., after exposure to chemical injury, mechanical injury, or neurodegenerative disease), their effects on growing neurons should not be ignored in clinical practice. In the present study, we have morphologically examined and compared the effects of the local anesthetics; lidocaine, bupivacaine, mepivacaine, and ropivacaine on growing neurites. To assess these effects quantitatively, we assayed growth cone collapse of cultured chick peripheral neurons. Growth cones play an important role in the development of the nervous system, such as guidance of neurite extension and establishment of neurite cytoarchitecture (9). The growth cone collapse assay is the established quantifying method of examining the effects of substances on developing neurites (10).
| Methods |
|---|
|
|
|---|
Lidocaine and bupivacaine were purchased from Sigma Co. Ltd. (St Louis, MO). Mepivacaine was purchased from US Pharmacopeia (Rockville, MD). Ropivacaine was obtained from AstraZeneca (London, UK). The local anesthetics were prepared in prewarmed fresh culture media at concentrations 100 times those to be obtained in the media. The volume of the added local anesthetic solution was 1/100 of the total volume of the culture media to obtain final concentrations of 10-4, 10-3, 10-2.3, 10-2, and 10-1.3 M of each of the local anesthetics for the dose response experiments. The local anesthetic solution was gently added to culture media of the DRG after 20 h in cultures. The pH of the culture media was measured using stat profile 5 and was not changed after the addition of the local anesthetic in each experiment. The osmolality of all solutions was measured with a vapor pressure osmometer; it was maintained within an acceptable range. A negative control was included in every experiment where no local anesthetic was added to the culture media to detect any time effect during the experiments. The cultured neurons were examined for the dose responses at 15, 30, and 60 min after the addition of the local anesthetics. In the experiment in which the effect of washout was examined, the tissues were kept in the incubator for 60 min after the addition of the drugs, and then the media were gently replaced twice with the fresh prewarmed media that was free from any local anesthetic drug. In an experiment to detect if the application of a larger concentration of NGF will affect the results of washout, fresh media with 100 ng/mL NGF was used as the replacement media
After the exchange of the media, the tissues were incubated for further 1, 2, and 20 h. The tissues were fixed with 4% paraformaldhyde in phosphate-buffered saline pH 7.4 containing 10% sucrose as described previously (12), and viewed with a 40 x phase objective using a phase-contrast microscope. Growth cones at the periphery of the explants were scored for the growth cone collapse assay providing that they were not in contact or close proximity to the other growth cones or neurite. Fifty to 100 growth cones were viewed on a coverslip for scoring and those without filopodia or lamellipodia were counted as collapsed (10).
Data are presented as mean and SD of six independent measurements. IC50 values in the growth cone collapse assays were calculated with the conventional Hill equation, Y = 100 x X/(X + IC50), using a curve fitting software, Origin 6.0J (Microcal Software, Northampton, MA). As Y = the percentage of growth cone collapse induced by the local anesthetic drug and X = the corresponding concentration of that drug. One-way analysis of variance for repeated mea-surements was used to determine statistically significant differences between the curves of growth cone collapse. Each result of the growth cone collapse assays was statistically analyzed by two-way analysis of variance with the Scheffes method using StatView 5.0 (SAS Institute, Cary, NC).
| Results |
|---|
|
|
|---|
|
|
|
|
| Discussion |
|---|
|
|
|---|
In a previous histopathological study, Kanai et al. (18) demonstrated that 80 mM (2.17%) lidocaine induced neuronal damage in rat sciatic nerve. Electrophysiological studies have used desheathed peripheral nerve models to assess electrophysiologic neurotoxicity of clinically relevant concentrations of some local anesthetics. These studies showed that 5% (184.5 mM) lidocaine causes irreversible conduction block, whereas 1.5% (55.4 mM) lidocaine and 0.75% (23.1 mM) bupivacaine do not (1921). No structural nerve damage was detected after intrafascicular injection of 0.5% (15.4 mM) bupivacaine in peripheral nerves of neonatal and juvenile rats (22). However, 1.9% (58.5 mM) bupivacaine induced significant histologic damage after intrathecal infusion in rats (23). It was difficult to compare these results, as the exposure methods were completely different from the present study. Gold et al. (24) showed that the application of lidocaine to DRG neurons isolated from adult rat causes neuronal death at concentrations larger than 10 mM. Thus, the potential neurotoxic effects observed in this study might be unique to growing neurons.
Local anesthetics can be neurotoxic, particularly in concentrations and doses larger than those used clinically (4). In the present study, we observed that four of the commonly used local anesthetics induced growth cone collapse at concentrations smaller than the clinically prepared concentrations. Lidocaine caused more extensive nerve damage than bupivacaine and mepivacaine in previous studies (3). In histopathologic, electrophysiologic, behavioral, and neuronal cell models, lidocaine seems to have a greater potential for neurotoxicity than bupivacaine at clinically relevant concentrations (4). These results are comparable to our results in respect to the comparative toxicity of local anesthetics.
Our observations suggest that local anesthetic-induced toxicity results from direct action of the drug. The pH of the culture media was not changed with the application of local anesthetics. Also, osmolality was maintained within an acceptable range. Sodium chloride, sodium salicylate, and sodium sulfate induced no significant growth cone collapse at concentrations up to 10-1 M in a previous study (25). Other histological studies support the suggestion that local anesthetics produce direct neurological damage (3,4). Increase in intracellular Ca2+ ions (24), and irreversible loss of membrane potential, which implies membrane disruption (18,20), have been reported as underlying mechanisms of lidocaine-induced toxicity and irreversible loss of membrane potential.
By washing out the local anesthetics-containing media after one-hour exposure, some reversibility of growth cone collapse was observed. However, when the assay was performed 20 hours after the washout, the percentage of growth cone collapse was significantly larger for lidocaine and mepivacaine than the control values (Fig. 3). However, the growth cone collapse induced by bupivacaine and ropivacaine was significantly attenuated at 20 hours after washout. Perhaps, the neurotoxic effects of bupivacaine and ropivacaine are more reversible compared with the other local anesthetics. Although the results of these washout experiments could not be directly applied in clinical settings, the issue that the neurotoxic effects induced by bupivacaine and ropivacaine were more reversible in vitro compared with the other local anesthetics should be considered. However, it is a remarkable fact that the growth cone collapse continued after removal of local anesthetics from the culture media and the number of intact growth cones did not completely return to the control values for any of the local anesthetics. It is suggested that the cellular processes involved in local anesthetic induced neuronal toxicity are initiated by exposure and proceed further even after stoppage of this exposure. Although the mechanism is not completely understood, the increase in intracellular Ca2+ ions as short as 5 min may be sufficient to induce delayed neuronal death (26). The washout effects were studied within 48 hours of plating (20 hours after the washout) to avoid contact of DRG with each other and the possibility of direct interactions among the cells.
If the effects demonstrated in this study occur in vivo, application of local anesthetics may interfere with the growth and regeneration of neuronal tissue. Thus, the potential risk of using local anesthetics in very young children should be considered.
In conclusion, local anesthetics induced morphological changes in growing neurons, impairing their growth in vitro. There are significant differences in this neurotoxic potential among local anesthetics. Also, different degrees of reversibility were observed after replacement of culture media. Although the results of this in vitro study could not be directly applied in vivo, the detrimental effects of local anesthetics to growing or regenerating neurons should be considered.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J.-W. Yi, B.-J. Lee, D.-O. Kim, S.-W. Park, Y.-K. Choi, H.-K. Chang, C.-J. Kim, and J.-H. Park Effects of bupivacaine and ropivacaine on field potential in rat hippocampal slices Br. J. Anaesth., May 1, 2009; 102(5): 673 - 679. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Luo, M. Yu, S. D. Smith, M. Kritzer, C. Du, Y. Ma, N. D. Volkow, P. S. Glass, and H. Benveniste The Effect of Intravenous Lidocaine on Brain Activation During Non-Noxious and Acute Noxious Stimulation of the Forepaw: A Functional Magnetic Resonance Imaging Study in the Rat Anesth. Analg., January 1, 2009; 108(1): 334 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Umbrain, L. Shi, M.-H. Lauwers, I. Smolders, Y. Michotte, and F. Camu Intrathecal lidocaine elevates prostaglandin E2 levels in cerebrospinal fluid: a microdialysis study in freely moving rats Br. J. Anaesth., November 1, 2008; 101(5): 716 - 722. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lirk, I. Haller, H. P. Colvin, L. Lang, B. Tomaselli, L. Klimaschewski, and P. Gerner In Vitro, Inhibition of Mitogen-Activated Protein Kinase Pathways Protects Against Bupivacaine- and Ropivacaine-Induced Neurotoxicity Anesth. Analg., May 1, 2008; 106(5): 1456 - 1464. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lirk, I. Haller, H. P. Colvin, S. Frauscher, L. Kirchmair, P. Gerner, and L. Klimaschewski In Vitro, Lidocaine-Induced Axonal Injury Is Prevented by Peripheral Inhibition of the p38 Mitogen-Activated Protein Kinase, but Not by Inhibiting Caspase Activity Anesth. Analg., December 1, 2007; 105(6): 1657 - 1664. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Rohm and J. Boldt Persisting Neurological Symptoms After Uncomplicated Intrathecal Bupivacaine Anesth. Analg., October 1, 2006; 103(4): 1047 - 1047. [Full Text] [PDF] |
||||
![]() |
C.J. Park, S.A. Park, T.G. Yoon, S.J. Lee, K.W. Yum, and H.J. Kim Bupivacaine Induces Apoptosis via ROS in the Schwann Cell Line Journal of Dental Research, September 1, 2005; 84(9): 852 - 857. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wiertlewski, A. Magot, S. Drapier, J.-M. Malinovsky, and Y. Pereon Worsening of Neurologic Symptoms After Epidural Anesthesia for Labor in a Guillain-Barre Patient Anesth. Analg., March 1, 2004; 98(3): 825 - 827. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Saito, I. A. M. Radwan, K. Nishikawa, H. Obata, T. Okamoto, T. Kanno, and F. Goto Intracellular Calcium Increases in Growth Cones Exposed to Tetracaine Anesth. Analg., March 1, 2004; 98(3): 841 - 845. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. M. Radwan, S. Saito, and F. Goto Neurotrophic Factors Can Partially Reverse Morphological Changes Induced by Mepivacaine and Bupivacaine in Developing Sensory Neurons Anesth. Analg., August 1, 2003; 97(2): 506 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kasaba, S. Onizuka, and M. Takasaki Procaine and Mepivacaine Have Less Toxicity In Vitro Than Other Clinically Used Local Anesthetics Anesth. Analg., July 1, 2003; 97(1): 85 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Eisenach, T. L. Yaksh, P. Marhofer, and M. Semsroth Epidural Ketamine in Healthy Children--What's the Point? * Response Anesth. Analg., February 1, 2003; 96(2): 626 - 627. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|